H7N9 shows some worrisome resistance to antivirals

07/16/2013 | DoctorsLounge.com

More than one-third of H7N9 avian influenza tested in a new study was resistant to the antiviral drugs Tamiflu (oseltamivir) and Relenza (zanamivir), and lab tests failed to detect the resistance, making it tough to monitor, a new study says. "If H7N9 does acquire human-to-human transmissibility, what do we have to treat it with until we have a vaccine? Oseltamivir. We would be in big trouble," said researcher Robert Webster. "We'd better get some vaccine seed stocks up and ready. The antiviral option for controlling H7N9 isn't too good."

View Full Article in:

DoctorsLounge.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT